2022 Q1 Form 10-Q Financial Statement
#000149315222013396 Filed on May 16, 2022
Income Statement
Concept | 2022 Q1 | 2021 Q1 |
---|---|---|
Revenue | $16.00K | $18.00K |
YoY Change | -11.11% | -30.77% |
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $4.294M | $14.91M |
YoY Change | -71.19% | 2163.29% |
% of Gross Profit | ||
Research & Development | $775.3K | $165.3K |
YoY Change | 369.19% | -11.31% |
% of Gross Profit | ||
Depreciation & Amortization | $26.01K | $24.20K |
YoY Change | 7.48% | -44.7% |
% of Gross Profit | ||
Operating Expenses | $5.070M | $15.07M |
YoY Change | -66.36% | 1683.77% |
Operating Profit | -$5.054M | |
YoY Change | ||
Interest Expense | -$29.01K | -$598.7K |
YoY Change | -95.15% | -82.86% |
% of Operating Profit | ||
Other Income/Expense, Net | $16.65K | |
YoY Change | ||
Pretax Income | -$4.816M | -$15.65M |
YoY Change | -69.23% | 107.31% |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$4.816M | -$15.65M |
YoY Change | -69.23% | 107.31% |
Net Earnings / Revenue | -30100.94% | -86962.94% |
Basic Earnings Per Share | -$1.37 | |
Diluted Earnings Per Share | -$1.367M | -$21.44M |
COMMON SHARES | ||
Basic Shares Outstanding | 3.523M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2022 Q1 | 2021 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $19.32M | $2.501M |
YoY Change | 672.62% | 52220.29% |
Cash & Equivalents | $19.32M | |
Short-Term Investments | ||
Other Short-Term Assets | $540.3K | $75.45K |
YoY Change | 616.08% | 239.56% |
Inventory | ||
Prepaid Expenses | ||
Receivables | $16.00K | $18.00K |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $19.88M | $2.594M |
YoY Change | 666.23% | 4795.02% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $469.0K | $461.2K |
YoY Change | 1.69% | -23.68% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $1.040M | $1.107M |
YoY Change | -6.03% | -16.45% |
TOTAL ASSETS | ||
Total Short-Term Assets | $19.88M | $2.594M |
Total Long-Term Assets | $1.040M | $1.107M |
Total Assets | $20.92M | $3.701M |
YoY Change | 465.2% | 168.65% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $213.9K | $245.7K |
YoY Change | -12.93% | -88.01% |
Accrued Expenses | $279.9K | $1.031M |
YoY Change | -72.86% | -73.69% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | $0.00 | $14.69K |
YoY Change | -100.0% | -99.82% |
Total Short-Term Liabilities | $493.8K | $1.292M |
YoY Change | -61.77% | -92.99% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $4.712M |
YoY Change | -100.0% | |
Other Long-Term Liabilities | $268.4K | $392.3K |
YoY Change | -31.59% | -21.19% |
Total Long-Term Liabilities | $268.4K | $5.104M |
YoY Change | -94.74% | 925.48% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $493.8K | $1.292M |
Total Long-Term Liabilities | $268.4K | $5.104M |
Total Liabilities | $762.2K | $6.396M |
YoY Change | -88.08% | -66.19% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | ||
YoY Change | ||
Common Stock | ||
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $20.16M | -$2.694M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $20.92M | $3.701M |
YoY Change | 465.2% | 168.65% |
Cashflow Statement
Concept | 2022 Q1 | 2021 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$4.816M | -$15.65M |
YoY Change | -69.23% | 107.31% |
Depreciation, Depletion And Amortization | $26.01K | $24.20K |
YoY Change | 7.48% | -44.7% |
Cash From Operating Activities | -$1.595M | -$813.7K |
YoY Change | 95.97% | 81.37% |
INVESTING ACTIVITIES | ||
Capital Expenditures | -$109.6K | |
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | -$109.6K | |
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 250.0K | |
YoY Change | -44.66% | |
NET CHANGE | ||
Cash From Operating Activities | -1.595M | -813.7K |
Cash From Investing Activities | -109.6K | |
Cash From Financing Activities | 250.0K | |
Net Change In Cash | $0.00 | $0.00 |
YoY Change | -100.0% | |
FREE CASH FLOW | ||
Cash From Operating Activities | -$1.595M | -$813.7K |
Capital Expenditures | -$109.6K | |
Free Cash Flow | -$1.485M | |
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
392256 | USD |
CY2022Q1 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
USD | |
CY2022Q1 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
USD | |
CY2021Q1 | BRTX |
Gain On Ppp Loan Forgiveness
GainOnPppLoanForgiveness
|
USD | |
CY2022Q1 | BRTX |
Amortization Of Debt Discount
AmortizationOfDebtDiscount
|
USD | |
CY2021Q1 | BRTX |
Grant Income
GrantIncome
|
USD | |
CY2021Q1 | BRTX |
Shares Issued In Cashless Exercise Of Warrants
SharesIssuedInCashlessExerciseOfWarrants
|
USD | |
CY2022Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
USD | |
CY2021Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
USD | |
CY2021Q1 | BRTX |
Gain On Ppp Loan Forgiveness
GainOnPppLoanForgiveness
|
USD | |
CY2021Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
USD | |
CY2021Q1 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
USD | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
USD | |
CY2022Q1 | BRTX |
Proceeds From Ppp Loan
ProceedsFromPppLoan
|
USD | |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
USD | |
CY2022Q1 | us-gaap |
Stock Issued1
StockIssued1
|
USD | |
CY2022Q1 | BRTX |
Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
|
USD | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
USD | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
USD | |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
USD | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
USD | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
USD | |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
USD |